nodes	percent_of_prediction	percent_of_DWPC	metapath
Sunitinib—pancreatic cancer—kidney cancer	0.162	1	CtDrD
Sunitinib—Protein Kinase Inhibitors—Temsirolimus—kidney cancer	0.159	0.465	CiPCiCtD
Sunitinib—Protein Kinase Inhibitors—Pazopanib—kidney cancer	0.0911	0.267	CiPCiCtD
Sunitinib—Protein Kinase Inhibitors—Everolimus—kidney cancer	0.0911	0.267	CiPCiCtD
Sunitinib—DAPK1—kidney cancer	0.0452	0.295	CbGaD
Sunitinib—LRRK2—kidney cancer	0.0318	0.208	CbGaD
Sunitinib—FLT1—kidney cancer	0.0227	0.148	CbGaD
Sunitinib—ALK—kidney cancer	0.0227	0.148	CbGaD
Sunitinib—KDR—kidney cancer	0.0142	0.0929	CbGaD
Sunitinib—KIT—kidney cancer	0.0134	0.0877	CbGaD
Sunitinib—RIOK2—Pazopanib—kidney cancer	0.0116	0.0544	CbGbCtD
Sunitinib—ITK—Pazopanib—kidney cancer	0.0116	0.0544	CbGbCtD
Sunitinib—STK16—Pazopanib—kidney cancer	0.00836	0.0393	CbGbCtD
Sunitinib—HIPK3—Sorafenib—kidney cancer	0.00671	0.0315	CbGbCtD
Sunitinib—FLT1—Pazopanib—kidney cancer	0.00664	0.0312	CbGbCtD
Sunitinib—AURKC—Pazopanib—kidney cancer	0.00664	0.0312	CbGbCtD
Sunitinib—TNK1—Erlotinib—kidney cancer	0.00596	0.028	CbGbCtD
Sunitinib—ULK3—Erlotinib—kidney cancer	0.00596	0.028	CbGbCtD
Sunitinib—FLT4—Pazopanib—kidney cancer	0.00555	0.0261	CbGbCtD
Sunitinib—FGFR2—Pazopanib—kidney cancer	0.00555	0.0261	CbGbCtD
Sunitinib—PLK4—Pazopanib—kidney cancer	0.00555	0.0261	CbGbCtD
Sunitinib—TAOK3—Pazopanib—kidney cancer	0.00555	0.0261	CbGbCtD
Sunitinib—FGFR1—Pazopanib—kidney cancer	0.00555	0.0261	CbGbCtD
Sunitinib—MAP3K2—Pazopanib—kidney cancer	0.0048	0.0226	CbGbCtD
Sunitinib—KDR—Pazopanib—kidney cancer	0.0048	0.0226	CbGbCtD
Sunitinib—AURKC—Erlotinib—kidney cancer	0.00474	0.0223	CbGbCtD
Sunitinib—EPHB6—Pazopanib—kidney cancer	0.00424	0.02	CbGbCtD
Sunitinib—SLK—Erlotinib—kidney cancer	0.00396	0.0186	CbGbCtD
Sunitinib—MAP3K7—Sorafenib—kidney cancer	0.00385	0.0181	CbGbCtD
Sunitinib—AURKC—Sorafenib—kidney cancer	0.00385	0.0181	CbGbCtD
Sunitinib—FLT1—Sorafenib—kidney cancer	0.00385	0.0181	CbGbCtD
Sunitinib—CSF1R—Pazopanib—kidney cancer	0.00381	0.0179	CbGbCtD
Sunitinib—PDGFRA—Pazopanib—kidney cancer	0.00381	0.0179	CbGbCtD
Sunitinib—KIT—Pazopanib—kidney cancer	0.00381	0.0179	CbGbCtD
Sunitinib—STK10—Pazopanib—kidney cancer	0.00381	0.0179	CbGbCtD
Sunitinib—MAP2K5—Pazopanib—kidney cancer	0.00347	0.0163	CbGbCtD
Sunitinib—PDGFRB—Pazopanib—kidney cancer	0.00347	0.0163	CbGbCtD
Sunitinib—FLT3—Erlotinib—kidney cancer	0.00342	0.0161	CbGbCtD
Sunitinib—FLT4—Sorafenib—kidney cancer	0.00322	0.0152	CbGbCtD
Sunitinib—FGFR1—Sorafenib—kidney cancer	0.00322	0.0152	CbGbCtD
Sunitinib—MAP3K19—Pazopanib—kidney cancer	0.00319	0.015	CbGbCtD
Sunitinib—ABCB1—kidney cancer	0.00309	0.0202	CbGaD
Sunitinib—HIPK4—Erlotinib—kidney cancer	0.00303	0.0142	CbGbCtD
Sunitinib—FLT3—Sorafenib—kidney cancer	0.00278	0.0131	CbGbCtD
Sunitinib—KDR—Sorafenib—kidney cancer	0.00278	0.0131	CbGbCtD
Sunitinib—RET—Sorafenib—kidney cancer	0.00278	0.0131	CbGbCtD
Sunitinib—STK10—Erlotinib—kidney cancer	0.00272	0.0128	CbGbCtD
Sunitinib—MAP2K5—Erlotinib—kidney cancer	0.00248	0.0116	CbGbCtD
Sunitinib—HIPK4—Sorafenib—kidney cancer	0.00246	0.0116	CbGbCtD
Sunitinib—EPHB6—Sorafenib—kidney cancer	0.00246	0.0116	CbGbCtD
Sunitinib—MAP3K19—Erlotinib—kidney cancer	0.00228	0.0107	CbGbCtD
Sunitinib—STK10—Sorafenib—kidney cancer	0.00221	0.0104	CbGbCtD
Sunitinib—CSF1R—Sorafenib—kidney cancer	0.00221	0.0104	CbGbCtD
Sunitinib—PDGFRA—Sorafenib—kidney cancer	0.00221	0.0104	CbGbCtD
Sunitinib—KIT—Sorafenib—kidney cancer	0.00221	0.0104	CbGbCtD
Sunitinib—PDGFRB—Sorafenib—kidney cancer	0.00201	0.00947	CbGbCtD
Sunitinib—MAP2K5—Sorafenib—kidney cancer	0.00201	0.00947	CbGbCtD
Sunitinib—MAP3K19—Sorafenib—kidney cancer	0.00185	0.0087	CbGbCtD
Sunitinib—CYP3A7-CYP3A51P—Temsirolimus—kidney cancer	0.000885	0.00416	CbGbCtD
Sunitinib—CYP3A7—Temsirolimus—kidney cancer	0.000885	0.00416	CbGbCtD
Sunitinib—ABCC4—Sorafenib—kidney cancer	0.000679	0.0032	CbGbCtD
Sunitinib—CYP3A5—Temsirolimus—kidney cancer	0.000664	0.00312	CbGbCtD
Sunitinib—ABCG2—Pazopanib—kidney cancer	0.00063	0.00296	CbGbCtD
Sunitinib—ABCG2—Dactinomycin—kidney cancer	0.000576	0.00271	CbGbCtD
Sunitinib—ABCC2—Paclitaxel—kidney cancer	0.000455	0.00214	CbGbCtD
Sunitinib—ABCG2—Erlotinib—kidney cancer	0.000449	0.00211	CbGbCtD
Sunitinib—ABCB1—Temsirolimus—kidney cancer	0.000432	0.00203	CbGbCtD
Sunitinib—ABCG2—Paclitaxel—kidney cancer	0.000411	0.00193	CbGbCtD
Sunitinib—ABCC2—Sorafenib—kidney cancer	0.000404	0.0019	CbGbCtD
Sunitinib—ABCC2—Vinblastine—kidney cancer	0.000399	0.00188	CbGbCtD
Sunitinib—ABCC2—Vincristine—kidney cancer	0.000392	0.00185	CbGbCtD
Sunitinib—CYP3A4—Everolimus—kidney cancer	0.000383	0.0018	CbGbCtD
Sunitinib—ABCG2—Sorafenib—kidney cancer	0.000365	0.00172	CbGbCtD
Sunitinib—ABCG2—Vincristine—kidney cancer	0.000355	0.00167	CbGbCtD
Sunitinib—CYP3A7—Paclitaxel—kidney cancer	0.000304	0.00143	CbGbCtD
Sunitinib—CYP3A7-CYP3A51P—Paclitaxel—kidney cancer	0.000304	0.00143	CbGbCtD
Sunitinib—CYP3A7—Sorafenib—kidney cancer	0.00027	0.00127	CbGbCtD
Sunitinib—CYP3A7-CYP3A51P—Sorafenib—kidney cancer	0.00027	0.00127	CbGbCtD
Sunitinib—CYP3A7—Vincristine—kidney cancer	0.000262	0.00123	CbGbCtD
Sunitinib—CYP3A7-CYP3A51P—Vincristine—kidney cancer	0.000262	0.00123	CbGbCtD
Sunitinib—CYP3A4—Temsirolimus—kidney cancer	0.000259	0.00122	CbGbCtD
Sunitinib—CYP3A5—Erlotinib—kidney cancer	0.000249	0.00117	CbGbCtD
Sunitinib—ABCC2—Doxorubicin—kidney cancer	0.000245	0.00115	CbGbCtD
Sunitinib—CYP3A5—Paclitaxel—kidney cancer	0.000228	0.00107	CbGbCtD
Sunitinib—ABCB1—Pazopanib—kidney cancer	0.000227	0.00107	CbGbCtD
Sunitinib—ABCG2—Doxorubicin—kidney cancer	0.000222	0.00104	CbGbCtD
Sunitinib—ABCB1—Dactinomycin—kidney cancer	0.000208	0.000977	CbGbCtD
Sunitinib—CYP3A5—Sorafenib—kidney cancer	0.000202	0.000952	CbGbCtD
Sunitinib—CYP3A5—Vincristine—kidney cancer	0.000196	0.000924	CbGbCtD
Sunitinib—Procainamide—ACHE—kidney cancer	0.00019	0.63	CrCbGaD
Sunitinib—ABCB1—Gemcitabine—kidney cancer	0.000164	0.000772	CbGbCtD
Sunitinib—ABCB1—Erlotinib—kidney cancer	0.000162	0.000762	CbGbCtD
Sunitinib—ABCB1—Paclitaxel—kidney cancer	0.000148	0.000698	CbGbCtD
Sunitinib—CYP3A4—Pazopanib—kidney cancer	0.000136	0.00064	CbGbCtD
Sunitinib—ABCB1—Sorafenib—kidney cancer	0.000132	0.00062	CbGbCtD
Sunitinib—ABCB1—Vinblastine—kidney cancer	0.00013	0.000612	CbGbCtD
Sunitinib—ABCB1—Vincristine—kidney cancer	0.000128	0.000601	CbGbCtD
Sunitinib—Procainamide—BCHE—kidney cancer	0.000112	0.37	CrCbGaD
Sunitinib—PRPF4—renal system—kidney cancer	0.000105	0.0038	CbGeAlD
Sunitinib—NUAK1—cortex of kidney—kidney cancer	0.000105	0.00378	CbGeAlD
Sunitinib—SNRK—cortex of kidney—kidney cancer	0.000104	0.00375	CbGeAlD
Sunitinib—OXSR1—cortex of kidney—kidney cancer	0.000104	0.00375	CbGeAlD
Sunitinib—INSR—cortex of kidney—kidney cancer	0.000104	0.00375	CbGeAlD
Sunitinib—PRPF4B—renal system—kidney cancer	0.000104	0.00374	CbGeAlD
Sunitinib—PKN1—kidney—kidney cancer	0.000103	0.00373	CbGeAlD
Sunitinib—ICK—cardiac atrium—kidney cancer	0.000103	0.00372	CbGeAlD
Sunitinib—STK39—renal system—kidney cancer	0.000103	0.00369	CbGeAlD
Sunitinib—RPS6KA2—cortex of kidney—kidney cancer	0.000102	0.00369	CbGeAlD
Sunitinib—STK38—cortex of kidney—kidney cancer	0.000102	0.00369	CbGeAlD
Sunitinib—PRPF4—kidney—kidney cancer	0.000102	0.00367	CbGeAlD
Sunitinib—HIPK2—nephron tubule—kidney cancer	0.000102	0.00367	CbGeAlD
Sunitinib—HIPK3—nephron tubule—kidney cancer	0.000102	0.00367	CbGeAlD
Sunitinib—CSNK2A1—renal system—kidney cancer	0.000101	0.00364	CbGeAlD
Sunitinib—RIOK2—nephron tubule—kidney cancer	0.000101	0.00363	CbGeAlD
Sunitinib—CSNK1G2—cortex of kidney—kidney cancer	0.000101	0.00363	CbGeAlD
Sunitinib—PRPF4B—kidney—kidney cancer	0.000101	0.00362	CbGeAlD
Sunitinib—MYLK—renal system—kidney cancer	9.99e-05	0.0036	CbGeAlD
Sunitinib—NUAK1—cardiac atrium—kidney cancer	9.97e-05	0.00359	CbGeAlD
Sunitinib—PRPF4—cortex of kidney—kidney cancer	9.93e-05	0.00358	CbGeAlD
Sunitinib—STK39—kidney—kidney cancer	9.91e-05	0.00357	CbGeAlD
Sunitinib—OXSR1—gonad—kidney cancer	9.91e-05	0.00357	CbGeAlD
Sunitinib—SNRK—gonad—kidney cancer	9.91e-05	0.00357	CbGeAlD
Sunitinib—OXSR1—cardiac atrium—kidney cancer	9.89e-05	0.00356	CbGeAlD
Sunitinib—INSR—cardiac atrium—kidney cancer	9.89e-05	0.00356	CbGeAlD
Sunitinib—SNRK—cardiac atrium—kidney cancer	9.89e-05	0.00356	CbGeAlD
Sunitinib—PRPF4B—cortex of kidney—kidney cancer	9.79e-05	0.00353	CbGeAlD
Sunitinib—CSNK2A1—kidney—kidney cancer	9.78e-05	0.00352	CbGeAlD
Sunitinib—STK38—gonad—kidney cancer	9.75e-05	0.00351	CbGeAlD
Sunitinib—RPS6KA2—cardiac atrium—kidney cancer	9.74e-05	0.00351	CbGeAlD
Sunitinib—STK38—cardiac atrium—kidney cancer	9.74e-05	0.00351	CbGeAlD
Sunitinib—CYP3A4—Erlotinib—kidney cancer	9.71e-05	0.000457	CbGbCtD
Sunitinib—AURKC—gonad—kidney cancer	9.67e-05	0.00348	CbGeAlD
Sunitinib—MYLK—kidney—kidney cancer	9.66e-05	0.00348	CbGeAlD
Sunitinib—STK39—cortex of kidney—kidney cancer	9.66e-05	0.00348	CbGeAlD
Sunitinib—CSNK1G2—gonad—kidney cancer	9.6e-05	0.00346	CbGeAlD
Sunitinib—PKN1—gonad—kidney cancer	9.6e-05	0.00346	CbGeAlD
Sunitinib—PKN1—cardiac atrium—kidney cancer	9.59e-05	0.00345	CbGeAlD
Sunitinib—CSNK1G2—cardiac atrium—kidney cancer	9.59e-05	0.00345	CbGeAlD
Sunitinib—CSNK2A1—cortex of kidney—kidney cancer	9.53e-05	0.00343	CbGeAlD
Sunitinib—PRPF4—gonad—kidney cancer	9.46e-05	0.00341	CbGeAlD
Sunitinib—PRPF4—cardiac atrium—kidney cancer	9.45e-05	0.0034	CbGeAlD
Sunitinib—MYLK—cortex of kidney—kidney cancer	9.41e-05	0.00339	CbGeAlD
Sunitinib—PRPF4B—gonad—kidney cancer	9.32e-05	0.00336	CbGeAlD
Sunitinib—PRPF4B—cardiac atrium—kidney cancer	9.31e-05	0.00335	CbGeAlD
Sunitinib—HIPK3—renal system—kidney cancer	9.27e-05	0.00334	CbGeAlD
Sunitinib—HIPK2—renal system—kidney cancer	9.27e-05	0.00334	CbGeAlD
Sunitinib—STK39—gonad—kidney cancer	9.2e-05	0.00331	CbGeAlD
Sunitinib—STK39—cardiac atrium—kidney cancer	9.18e-05	0.00331	CbGeAlD
Sunitinib—CSNK2A1—gonad—kidney cancer	9.07e-05	0.00327	CbGeAlD
Sunitinib—CSNK2A1—cardiac atrium—kidney cancer	9.06e-05	0.00326	CbGeAlD
Sunitinib—STK24—cortex of kidney—kidney cancer	9.02e-05	0.00325	CbGeAlD
Sunitinib—HIPK3—kidney—kidney cancer	8.96e-05	0.00323	CbGeAlD
Sunitinib—HIPK2—kidney—kidney cancer	8.96e-05	0.00323	CbGeAlD
Sunitinib—MYLK—gonad—kidney cancer	8.96e-05	0.00323	CbGeAlD
Sunitinib—MYLK—cardiac atrium—kidney cancer	8.95e-05	0.00322	CbGeAlD
Sunitinib—DAPK2—cortex of kidney—kidney cancer	8.92e-05	0.00321	CbGeAlD
Sunitinib—DAPK3—renal system—kidney cancer	8.9e-05	0.00321	CbGeAlD
Sunitinib—CYP3A4—Paclitaxel—kidney cancer	8.88e-05	0.000418	CbGbCtD
Sunitinib—PLK4—gonad—kidney cancer	8.85e-05	0.00319	CbGeAlD
Sunitinib—CLK2—renal system—kidney cancer	8.82e-05	0.00318	CbGeAlD
Sunitinib—MAP4K4—nephron tubule—kidney cancer	8.79e-05	0.00317	CbGeAlD
Sunitinib—NUAK2—nephron tubule—kidney cancer	8.73e-05	0.00314	CbGeAlD
Sunitinib—HIPK2—cortex of kidney—kidney cancer	8.73e-05	0.00314	CbGeAlD
Sunitinib—PHKG2—gonad—kidney cancer	8.64e-05	0.00311	CbGeAlD
Sunitinib—RIOK2—cortex of kidney—kidney cancer	8.64e-05	0.00311	CbGeAlD
Sunitinib—RPS6KA3—nephron tubule—kidney cancer	8.55e-05	0.00308	CbGeAlD
Sunitinib—ROCK1—renal system—kidney cancer	8.55e-05	0.00308	CbGeAlD
Sunitinib—DAPK2—cardiac atrium—kidney cancer	8.48e-05	0.00305	CbGeAlD
Sunitinib—CSNK1A1—nephron tubule—kidney cancer	8.38e-05	0.00302	CbGeAlD
Sunitinib—DYRK1A—renal system—kidney cancer	8.34e-05	0.003	CbGeAlD
Sunitinib—CLK1—nephron tubule—kidney cancer	8.33e-05	0.003	CbGeAlD
Sunitinib—HIPK3—gonad—kidney cancer	8.31e-05	0.00299	CbGeAlD
Sunitinib—TYRO3—gonad—kidney cancer	8.31e-05	0.00299	CbGeAlD
Sunitinib—HIPK2—gonad—kidney cancer	8.31e-05	0.00299	CbGeAlD
Sunitinib—CLK2—cortex of kidney—kidney cancer	8.3e-05	0.00299	CbGeAlD
Sunitinib—HIPK3—cardiac atrium—kidney cancer	8.3e-05	0.00299	CbGeAlD
Sunitinib—ROCK1—kidney—kidney cancer	8.26e-05	0.00298	CbGeAlD
Sunitinib—RIOK2—cardiac atrium—kidney cancer	8.21e-05	0.00296	CbGeAlD
Sunitinib—STK3—cortex of kidney—kidney cancer	8.16e-05	0.00294	CbGeAlD
Sunitinib—CHEK2—Docetaxel—Paclitaxel—kidney cancer	8.11e-05	0.0937	CbGdCrCtD
Sunitinib—DYRK1A—kidney—kidney cancer	8.06e-05	0.0029	CbGeAlD
Sunitinib—MAP4K4—renal system—kidney cancer	7.99e-05	0.00288	CbGeAlD
Sunitinib—ABCB1—Doxorubicin—kidney cancer	7.99e-05	0.000376	CbGbCtD
Sunitinib—RPS6KA1—Sirolimus—Everolimus—kidney cancer	7.98e-05	0.0922	CbGdCrCtD
Sunitinib—RPS6KA1—Sirolimus—Temsirolimus—kidney cancer	7.98e-05	0.0922	CbGdCrCtD
Sunitinib—RPS6KA1—Temsirolimus—Everolimus—kidney cancer	7.98e-05	0.0922	CbGdCrCtD
Sunitinib—DAPK3—cardiac atrium—kidney cancer	7.97e-05	0.00287	CbGeAlD
Sunitinib—CLK2—gonad—kidney cancer	7.91e-05	0.00285	CbGeAlD
Sunitinib—CLK2—cardiac atrium—kidney cancer	7.9e-05	0.00284	CbGeAlD
Sunitinib—CYP3A4—Sorafenib—kidney cancer	7.89e-05	0.000371	CbGbCtD
Sunitinib—CYP3A4—Vinblastine—kidney cancer	7.79e-05	0.000367	CbGbCtD
Sunitinib—RPS6KA3—renal system—kidney cancer	7.77e-05	0.0028	CbGeAlD
Sunitinib—MAP4K4—kidney—kidney cancer	7.73e-05	0.00278	CbGeAlD
Sunitinib—MAP2K1—renal system—kidney cancer	7.72e-05	0.00278	CbGeAlD
Sunitinib—ROCK1—gonad—kidney cancer	7.67e-05	0.00276	CbGeAlD
Sunitinib—CYP3A4—Vincristine—kidney cancer	7.66e-05	0.00036	CbGbCtD
Sunitinib—CSNK1A1—renal system—kidney cancer	7.62e-05	0.00274	CbGeAlD
Sunitinib—CLK1—renal system—kidney cancer	7.57e-05	0.00273	CbGeAlD
Sunitinib—RPS6KA3—kidney—kidney cancer	7.51e-05	0.00271	CbGeAlD
Sunitinib—DYRK1A—gonad—kidney cancer	7.48e-05	0.00269	CbGeAlD
Sunitinib—NUAK2—cortex of kidney—kidney cancer	7.47e-05	0.00269	CbGeAlD
Sunitinib—MAP2K1—kidney—kidney cancer	7.46e-05	0.00269	CbGeAlD
Sunitinib—MAP3K2—nephron tubule—kidney cancer	7.42e-05	0.00267	CbGeAlD
Sunitinib—CSNK1A1—kidney—kidney cancer	7.37e-05	0.00265	CbGeAlD
Sunitinib—LRRK2—renal system—kidney cancer	7.36e-05	0.00265	CbGeAlD
Sunitinib—CLK1—kidney—kidney cancer	7.32e-05	0.00264	CbGeAlD
Sunitinib—RPS6KA3—cortex of kidney—kidney cancer	7.32e-05	0.00264	CbGeAlD
Sunitinib—TBK1—nephron tubule—kidney cancer	7.27e-05	0.00262	CbGeAlD
Sunitinib—PRKAA1—renal system—kidney cancer	7.26e-05	0.00261	CbGeAlD
Sunitinib—TYK2—nephron tubule—kidney cancer	7.22e-05	0.0026	CbGeAlD
Sunitinib—PTK2B—renal system—kidney cancer	7.18e-05	0.00258	CbGeAlD
Sunitinib—CSNK1A1—cortex of kidney—kidney cancer	7.17e-05	0.00258	CbGeAlD
Sunitinib—MAP4K4—gonad—kidney cancer	7.17e-05	0.00258	CbGeAlD
Sunitinib—MAP4K4—cardiac atrium—kidney cancer	7.16e-05	0.00258	CbGeAlD
Sunitinib—CLK1—cortex of kidney—kidney cancer	7.13e-05	0.00257	CbGeAlD
Sunitinib—IRAK1—nephron tubule—kidney cancer	7.13e-05	0.00257	CbGeAlD
Sunitinib—LRRK2—kidney—kidney cancer	7.12e-05	0.00256	CbGeAlD
Sunitinib—MAP3K12—gonad—kidney cancer	7.07e-05	0.00254	CbGeAlD
Sunitinib—FLT3—gonad—kidney cancer	7.07e-05	0.00254	CbGeAlD
Sunitinib—MAP3K12—cardiac atrium—kidney cancer	7.06e-05	0.00254	CbGeAlD
Sunitinib—PRKAA1—kidney—kidney cancer	7.02e-05	0.00253	CbGeAlD
Sunitinib—CAMK2G—cortex of kidney—kidney cancer	7e-05	0.00252	CbGeAlD
Sunitinib—RPS6KA3—cardiac atrium—kidney cancer	6.96e-05	0.00251	CbGeAlD
Sunitinib—PTK2B—kidney—kidney cancer	6.94e-05	0.0025	CbGeAlD
Sunitinib—LRRK2—cortex of kidney—kidney cancer	6.93e-05	0.0025	CbGeAlD
Sunitinib—MAP2K1—gonad—kidney cancer	6.92e-05	0.00249	CbGeAlD
Sunitinib—CSNK1A1—gonad—kidney cancer	6.83e-05	0.00246	CbGeAlD
Sunitinib—CSNK1A1—cardiac atrium—kidney cancer	6.82e-05	0.00246	CbGeAlD
Sunitinib—MAP2K2—renal system—kidney cancer	6.8e-05	0.00245	CbGeAlD
Sunitinib—CLK1—gonad—kidney cancer	6.79e-05	0.00245	CbGeAlD
Sunitinib—CLK1—cardiac atrium—kidney cancer	6.78e-05	0.00244	CbGeAlD
Sunitinib—FLT4—cortex of kidney—kidney cancer	6.74e-05	0.00243	CbGeAlD
Sunitinib—SLK—nephron tubule—kidney cancer	6.66e-05	0.0024	CbGeAlD
Sunitinib—BMP2K—gonad—kidney cancer	6.66e-05	0.0024	CbGeAlD
Sunitinib—CSNK1E—cortex of kidney—kidney cancer	6.65e-05	0.00239	CbGeAlD
Sunitinib—FGFR1—cortex of kidney—kidney cancer	6.65e-05	0.00239	CbGeAlD
Sunitinib—TBK1—renal system—kidney cancer	6.61e-05	0.00238	CbGeAlD
Sunitinib—LRRK2—gonad—kidney cancer	6.6e-05	0.00238	CbGeAlD
Sunitinib—MAP2K2—kidney—kidney cancer	6.57e-05	0.00237	CbGeAlD
Sunitinib—TYK2—renal system—kidney cancer	6.56e-05	0.00236	CbGeAlD
Sunitinib—CYP3A4—urine—kidney cancer	6.52e-05	0.00235	CbGeAlD
Sunitinib—PRKAA1—gonad—kidney cancer	6.51e-05	0.00234	CbGeAlD
Sunitinib—FYN—nephron tubule—kidney cancer	6.48e-05	0.00233	CbGeAlD
Sunitinib—PTK2B—gonad—kidney cancer	6.44e-05	0.00232	CbGeAlD
Sunitinib—ULK3—cortex of kidney—kidney cancer	6.4e-05	0.0023	CbGeAlD
Sunitinib—MAP2K2—cortex of kidney—kidney cancer	6.4e-05	0.0023	CbGeAlD
Sunitinib—TBK1—kidney—kidney cancer	6.39e-05	0.0023	CbGeAlD
Sunitinib—RPS6KB1—renal system—kidney cancer	6.36e-05	0.00229	CbGeAlD
Sunitinib—TYK2—kidney—kidney cancer	6.35e-05	0.00229	CbGeAlD
Sunitinib—MAP3K3—nephron tubule—kidney cancer	6.33e-05	0.00228	CbGeAlD
Sunitinib—FGFR1—cardiac atrium—kidney cancer	6.32e-05	0.00228	CbGeAlD
Sunitinib—RET—renal system—kidney cancer	6.32e-05	0.00228	CbGeAlD
Sunitinib—MAP3K7—cortex of kidney—kidney cancer	6.29e-05	0.00227	CbGeAlD
Sunitinib—TBK1—cortex of kidney—kidney cancer	6.22e-05	0.00224	CbGeAlD
Sunitinib—TYK2—cortex of kidney—kidney cancer	6.18e-05	0.00223	CbGeAlD
Sunitinib—RPS6KB1—kidney—kidney cancer	6.15e-05	0.00221	CbGeAlD
Sunitinib—FLT1—nephron tubule—kidney cancer	6.12e-05	0.0022	CbGeAlD
Sunitinib—RET—kidney—kidney cancer	6.11e-05	0.0022	CbGeAlD
Sunitinib—IRAK1—cortex of kidney—kidney cancer	6.1e-05	0.0022	CbGeAlD
Sunitinib—ULK3—gonad—kidney cancer	6.09e-05	0.0022	CbGeAlD
Sunitinib—MAP2K2—gonad—kidney cancer	6.09e-05	0.0022	CbGeAlD
Sunitinib—MAP2K2—cardiac atrium—kidney cancer	6.09e-05	0.00219	CbGeAlD
Sunitinib—ULK3—cardiac atrium—kidney cancer	6.09e-05	0.00219	CbGeAlD
Sunitinib—MAP3K2—gonad—kidney cancer	6.05e-05	0.00218	CbGeAlD
Sunitinib—FGFR2—renal system—kidney cancer	6e-05	0.00216	CbGeAlD
Sunitinib—MAP3K7—cardiac atrium—kidney cancer	5.99e-05	0.00216	CbGeAlD
Sunitinib—RPS6KB1—cortex of kidney—kidney cancer	5.99e-05	0.00216	CbGeAlD
Sunitinib—JAK2—renal system—kidney cancer	5.97e-05	0.00215	CbGeAlD
Sunitinib—TBK1—gonad—kidney cancer	5.93e-05	0.00213	CbGeAlD
Sunitinib—AXL—cortex of kidney—kidney cancer	5.93e-05	0.00213	CbGeAlD
Sunitinib—TBK1—cardiac atrium—kidney cancer	5.92e-05	0.00213	CbGeAlD
Sunitinib—FYN—renal system—kidney cancer	5.89e-05	0.00212	CbGeAlD
Sunitinib—TYK2—cardiac atrium—kidney cancer	5.88e-05	0.00212	CbGeAlD
Sunitinib—YES1—nephron tubule—kidney cancer	5.85e-05	0.00211	CbGeAlD
Sunitinib—FGFR2—kidney—kidney cancer	5.8e-05	0.00209	CbGeAlD
Sunitinib—JAK2—kidney—kidney cancer	5.77e-05	0.00208	CbGeAlD
Sunitinib—TAOK3—nephron tubule—kidney cancer	5.77e-05	0.00208	CbGeAlD
Sunitinib—SLK—cortex of kidney—kidney cancer	5.7e-05	0.00205	CbGeAlD
Sunitinib—FYN—kidney—kidney cancer	5.69e-05	0.00205	CbGeAlD
Sunitinib—RPS6KB1—cardiac atrium—kidney cancer	5.69e-05	0.00205	CbGeAlD
Sunitinib—CYP3A7-CYP3A51P—nephron tubule—kidney cancer	5.65e-05	0.00203	CbGeAlD
Sunitinib—AXL—gonad—kidney cancer	5.64e-05	0.00203	CbGeAlD
Sunitinib—AXL—cardiac atrium—kidney cancer	5.64e-05	0.00203	CbGeAlD
Sunitinib—JAK2—cortex of kidney—kidney cancer	5.62e-05	0.00203	CbGeAlD
Sunitinib—PRPF4—Temsirolimus—Everolimus—kidney cancer	5.59e-05	0.0645	CbGdCrCtD
Sunitinib—PRPF4—Sirolimus—Everolimus—kidney cancer	5.59e-05	0.0645	CbGdCrCtD
Sunitinib—PRPF4—Sirolimus—Temsirolimus—kidney cancer	5.59e-05	0.0645	CbGdCrCtD
Sunitinib—FLT1—renal system—kidney cancer	5.56e-05	0.002	CbGeAlD
Sunitinib—FYN—cortex of kidney—kidney cancer	5.55e-05	0.002	CbGeAlD
Sunitinib—SLK—cardiac atrium—kidney cancer	5.43e-05	0.00195	CbGeAlD
Sunitinib—MAP3K3—cortex of kidney—kidney cancer	5.42e-05	0.00195	CbGeAlD
Sunitinib—MAP4K5—cortex of kidney—kidney cancer	5.42e-05	0.00195	CbGeAlD
Sunitinib—FLT1—kidney—kidney cancer	5.38e-05	0.00194	CbGeAlD
Sunitinib—JAK2—gonad—kidney cancer	5.36e-05	0.00193	CbGeAlD
Sunitinib—JAK2—cardiac atrium—kidney cancer	5.35e-05	0.00193	CbGeAlD
Sunitinib—YES1—renal system—kidney cancer	5.32e-05	0.00191	CbGeAlD
Sunitinib—FYN—cardiac atrium—kidney cancer	5.27e-05	0.0019	CbGeAlD
Sunitinib—STK10—renal system—kidney cancer	5.27e-05	0.0019	CbGeAlD
Sunitinib—TAOK3—renal system—kidney cancer	5.25e-05	0.00189	CbGeAlD
Sunitinib—FLT1—cortex of kidney—kidney cancer	5.24e-05	0.00189	CbGeAlD
Sunitinib—PDGFRA—renal system—kidney cancer	5.21e-05	0.00188	CbGeAlD
Sunitinib—EPHB6—cortex of kidney—kidney cancer	5.18e-05	0.00187	CbGeAlD
Sunitinib—KDR—nephron tubule—kidney cancer	5.17e-05	0.00186	CbGeAlD
Sunitinib—MAP4K5—gonad—kidney cancer	5.16e-05	0.00186	CbGeAlD
Sunitinib—MAP3K3—gonad—kidney cancer	5.16e-05	0.00186	CbGeAlD
Sunitinib—MAP3K3—cardiac atrium—kidney cancer	5.15e-05	0.00186	CbGeAlD
Sunitinib—MAP4K5—cardiac atrium—kidney cancer	5.15e-05	0.00186	CbGeAlD
Sunitinib—YES1—kidney—kidney cancer	5.14e-05	0.00185	CbGeAlD
Sunitinib—STK10—kidney—kidney cancer	5.09e-05	0.00183	CbGeAlD
Sunitinib—TAOK3—kidney—kidney cancer	5.07e-05	0.00183	CbGeAlD
Sunitinib—YES1—cortex of kidney—kidney cancer	5e-05	0.0018	CbGeAlD
Sunitinib—FLT1—gonad—kidney cancer	4.99e-05	0.0018	CbGeAlD
Sunitinib—FLT1—cardiac atrium—kidney cancer	4.98e-05	0.00179	CbGeAlD
Sunitinib—TAOK3—cortex of kidney—kidney cancer	4.94e-05	0.00178	CbGeAlD
Sunitinib—EPHB6—cardiac atrium—kidney cancer	4.93e-05	0.00177	CbGeAlD
Sunitinib—CYP3A7-CYP3A51P—cortex of kidney—kidney cancer	4.83e-05	0.00174	CbGeAlD
Sunitinib—CYP3A4—Doxorubicin—kidney cancer	4.79e-05	0.000225	CbGbCtD
Sunitinib—YES1—gonad—kidney cancer	4.77e-05	0.00172	CbGeAlD
Sunitinib—YES1—cardiac atrium—kidney cancer	4.76e-05	0.00171	CbGeAlD
Sunitinib—STK10—gonad—kidney cancer	4.72e-05	0.0017	CbGeAlD
Sunitinib—KDR—renal system—kidney cancer	4.7e-05	0.00169	CbGeAlD
Sunitinib—TAOK3—cardiac atrium—kidney cancer	4.7e-05	0.00169	CbGeAlD
Sunitinib—PDGFRA—gonad—kidney cancer	4.68e-05	0.00168	CbGeAlD
Sunitinib—KIT—nephron tubule—kidney cancer	4.59e-05	0.00165	CbGeAlD
Sunitinib—KDR—kidney—kidney cancer	4.55e-05	0.00164	CbGeAlD
Sunitinib—KDR—cortex of kidney—kidney cancer	4.43e-05	0.0016	CbGeAlD
Sunitinib—MAP2K5—cortex of kidney—kidney cancer	4.43e-05	0.0016	CbGeAlD
Sunitinib—KDR—cardiac atrium—kidney cancer	4.21e-05	0.00152	CbGeAlD
Sunitinib—MAP2K5—cardiac atrium—kidney cancer	4.21e-05	0.00152	CbGeAlD
Sunitinib—CAMK2G—Azacitidine—Gemcitabine—kidney cancer	4.19e-05	0.0484	CbGdCrCtD
Sunitinib—KIT—renal system—kidney cancer	4.17e-05	0.0015	CbGeAlD
Sunitinib—CHEK2—Vindesine—Vinblastine—kidney cancer	4.12e-05	0.0476	CbGdCrCtD
Sunitinib—CHEK2—Vindesine—Vincristine—kidney cancer	4.12e-05	0.0476	CbGdCrCtD
Sunitinib—CSF1R—gonad—kidney cancer	4.12e-05	0.00148	CbGeAlD
Sunitinib—CSF1R—cardiac atrium—kidney cancer	4.11e-05	0.00148	CbGeAlD
Sunitinib—PDGFRB—renal system—kidney cancer	4.07e-05	0.00147	CbGeAlD
Sunitinib—KIT—kidney—kidney cancer	4.03e-05	0.00145	CbGeAlD
Sunitinib—PDGFRB—kidney—kidney cancer	3.94e-05	0.00142	CbGeAlD
Sunitinib—KIT—cortex of kidney—kidney cancer	3.93e-05	0.00141	CbGeAlD
Sunitinib—PDGFRB—cortex of kidney—kidney cancer	3.83e-05	0.00138	CbGeAlD
Sunitinib—KIT—gonad—kidney cancer	3.74e-05	0.00135	CbGeAlD
Sunitinib—PDGFRB—gonad—kidney cancer	3.65e-05	0.00131	CbGeAlD
Sunitinib—PDGFRB—cardiac atrium—kidney cancer	3.65e-05	0.00131	CbGeAlD
Sunitinib—ABCC4—nephron tubule—kidney cancer	3.57e-05	0.00128	CbGeAlD
Sunitinib—ABCC2—nephron tubule—kidney cancer	3.45e-05	0.00124	CbGeAlD
Sunitinib—ABCC4—renal system—kidney cancer	3.24e-05	0.00117	CbGeAlD
Sunitinib—ABCC2—renal system—kidney cancer	3.14e-05	0.00113	CbGeAlD
Sunitinib—ABCC4—kidney—kidney cancer	3.13e-05	0.00113	CbGeAlD
Sunitinib—ABCC4—cortex of kidney—kidney cancer	3.05e-05	0.0011	CbGeAlD
Sunitinib—ABCC2—kidney—kidney cancer	3.03e-05	0.00109	CbGeAlD
Sunitinib—ABCC2—cortex of kidney—kidney cancer	2.95e-05	0.00106	CbGeAlD
Sunitinib—CHEK2—Vinorelbine—Vincristine—kidney cancer	2.6e-05	0.0301	CbGdCrCtD
Sunitinib—CHEK2—Vinorelbine—Vinblastine—kidney cancer	2.6e-05	0.0301	CbGdCrCtD
Sunitinib—KCNH2—renal system—kidney cancer	2.57e-05	0.000927	CbGeAlD
Sunitinib—ABCG2—nephron tubule—kidney cancer	2.52e-05	0.000907	CbGeAlD
Sunitinib—CYP3A5—nephron tubule—kidney cancer	2.34e-05	0.000842	CbGeAlD
Sunitinib—KCNH2—cardiac atrium—kidney cancer	2.3e-05	0.00083	CbGeAlD
Sunitinib—CHEK2—Vincristine—Vinblastine—kidney cancer	2.23e-05	0.0257	CbGdCrCtD
Sunitinib—RPS6KA1—Azacitidine—Gemcitabine—kidney cancer	2.15e-05	0.0248	CbGdCrCtD
Sunitinib—CYP3A5—renal system—kidney cancer	2.12e-05	0.000765	CbGeAlD
Sunitinib—DYRK1A—Epirubicin—Doxorubicin—kidney cancer	2.08e-05	0.0241	CbGdCrCtD
Sunitinib—DYRK1A—Idarubicin—Doxorubicin—kidney cancer	2.08e-05	0.0241	CbGdCrCtD
Sunitinib—DYRK1A—Daunorubicin—Doxorubicin—kidney cancer	2.08e-05	0.0241	CbGdCrCtD
Sunitinib—CYP3A5—kidney—kidney cancer	2.05e-05	0.00074	CbGeAlD
Sunitinib—CYP3A5—cortex of kidney—kidney cancer	2e-05	0.00072	CbGeAlD
Sunitinib—PRPF4—Daunorubicin—Doxorubicin—kidney cancer	1.8e-05	0.0208	CbGdCrCtD
Sunitinib—PRPF4—Idarubicin—Doxorubicin—kidney cancer	1.8e-05	0.0208	CbGdCrCtD
Sunitinib—CHEK2—Vinblastine—Vincristine—kidney cancer	1.79e-05	0.0207	CbGdCrCtD
Sunitinib—CYP3A4—renal system—kidney cancer	1.59e-05	0.000574	CbGeAlD
Sunitinib—CYP3A4—kidney—kidney cancer	1.54e-05	0.000555	CbGeAlD
Sunitinib—PLK4—Epirubicin—Doxorubicin—kidney cancer	1.42e-05	0.0164	CbGdCrCtD
Sunitinib—PLK4—Idarubicin—Doxorubicin—kidney cancer	1.42e-05	0.0164	CbGdCrCtD
Sunitinib—CHEK2—Epirubicin—Doxorubicin—kidney cancer	1.25e-05	0.0145	CbGdCrCtD
Sunitinib—ABCB1—nephron tubule—kidney cancer	1.24e-05	0.000447	CbGeAlD
Sunitinib—ABCB1—renal system—kidney cancer	1.13e-05	0.000406	CbGeAlD
Sunitinib—ABCB1—kidney—kidney cancer	1.09e-05	0.000393	CbGeAlD
Sunitinib—ABCB1—cortex of kidney—kidney cancer	1.06e-05	0.000383	CbGeAlD
Sunitinib—ABCB1—gonad—kidney cancer	1.01e-05	0.000364	CbGeAlD
Sunitinib—Leukopenia—Paclitaxel—kidney cancer	8.07e-06	0.000148	CcSEcCtD
Sunitinib—Decreased appetite—Vincristine—kidney cancer	8.05e-06	0.000148	CcSEcCtD
Sunitinib—Pruritus—Sorafenib—kidney cancer	8.05e-06	0.000148	CcSEcCtD
Sunitinib—Vomiting—Erlotinib—kidney cancer	8.04e-06	0.000147	CcSEcCtD
Sunitinib—Erythema multiforme—Capecitabine—kidney cancer	8.03e-06	0.000147	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Gemcitabine—kidney cancer	8.01e-06	0.000147	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Vincristine—kidney cancer	8e-06	0.000147	CcSEcCtD
Sunitinib—Fatigue—Vincristine—kidney cancer	7.99e-06	0.000146	CcSEcCtD
Sunitinib—Rash—Erlotinib—kidney cancer	7.98e-06	0.000146	CcSEcCtD
Sunitinib—Dermatitis—Erlotinib—kidney cancer	7.97e-06	0.000146	CcSEcCtD
Sunitinib—Hyponatraemia—Doxorubicin—kidney cancer	7.95e-06	0.000146	CcSEcCtD
Sunitinib—Insomnia—Gemcitabine—kidney cancer	7.95e-06	0.000146	CcSEcCtD
Sunitinib—Eye disorder—Capecitabine—kidney cancer	7.94e-06	0.000146	CcSEcCtD
Sunitinib—Headache—Erlotinib—kidney cancer	7.92e-06	0.000145	CcSEcCtD
Sunitinib—Pain—Vincristine—kidney cancer	7.92e-06	0.000145	CcSEcCtD
Sunitinib—Constipation—Vincristine—kidney cancer	7.92e-06	0.000145	CcSEcCtD
Sunitinib—Pain in extremity—Doxorubicin—kidney cancer	7.92e-06	0.000145	CcSEcCtD
Sunitinib—Paraesthesia—Gemcitabine—kidney cancer	7.89e-06	0.000145	CcSEcCtD
Sunitinib—Flushing—Capecitabine—kidney cancer	7.89e-06	0.000145	CcSEcCtD
Sunitinib—Cardiac disorder—Capecitabine—kidney cancer	7.89e-06	0.000145	CcSEcCtD
Sunitinib—Cough—Paclitaxel—kidney cancer	7.87e-06	0.000144	CcSEcCtD
Sunitinib—Dyspnoea—Gemcitabine—kidney cancer	7.83e-06	0.000144	CcSEcCtD
Sunitinib—Nausea—Vinblastine—kidney cancer	7.82e-06	0.000143	CcSEcCtD
Sunitinib—Convulsion—Paclitaxel—kidney cancer	7.81e-06	0.000143	CcSEcCtD
Sunitinib—Nausea—Everolimus—kidney cancer	7.79e-06	0.000143	CcSEcCtD
Sunitinib—Diarrhoea—Sorafenib—kidney cancer	7.79e-06	0.000143	CcSEcCtD
Sunitinib—Hypertension—Paclitaxel—kidney cancer	7.78e-06	0.000143	CcSEcCtD
Sunitinib—Angiopathy—Capecitabine—kidney cancer	7.71e-06	0.000141	CcSEcCtD
Sunitinib—Immune system disorder—Capecitabine—kidney cancer	7.68e-06	0.000141	CcSEcCtD
Sunitinib—Arthralgia—Paclitaxel—kidney cancer	7.67e-06	0.000141	CcSEcCtD
Sunitinib—Myalgia—Paclitaxel—kidney cancer	7.67e-06	0.000141	CcSEcCtD
Sunitinib—Chest pain—Paclitaxel—kidney cancer	7.67e-06	0.000141	CcSEcCtD
Sunitinib—Mediastinal disorder—Capecitabine—kidney cancer	7.66e-06	0.00014	CcSEcCtD
Sunitinib—Face oedema—Doxorubicin—kidney cancer	7.64e-06	0.00014	CcSEcCtD
Sunitinib—Decreased appetite—Gemcitabine—kidney cancer	7.64e-06	0.00014	CcSEcCtD
Sunitinib—Hypersensitivity—Dactinomycin—kidney cancer	7.64e-06	0.00014	CcSEcCtD
Sunitinib—Chills—Capecitabine—kidney cancer	7.62e-06	0.00014	CcSEcCtD
Sunitinib—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	7.62e-06	0.00014	CcSEcCtD
Sunitinib—Arrhythmia—Capecitabine—kidney cancer	7.59e-06	0.000139	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Gemcitabine—kidney cancer	7.59e-06	0.000139	CcSEcCtD
Sunitinib—Fatigue—Gemcitabine—kidney cancer	7.58e-06	0.000139	CcSEcCtD
Sunitinib—Gastrointestinal pain—Vincristine—kidney cancer	7.57e-06	0.000139	CcSEcCtD
Sunitinib—Dizziness—Sorafenib—kidney cancer	7.53e-06	0.000138	CcSEcCtD
Sunitinib—Pain—Gemcitabine—kidney cancer	7.51e-06	0.000138	CcSEcCtD
Sunitinib—Constipation—Gemcitabine—kidney cancer	7.51e-06	0.000138	CcSEcCtD
Sunitinib—Nausea—Erlotinib—kidney cancer	7.51e-06	0.000138	CcSEcCtD
Sunitinib—Alopecia—Capecitabine—kidney cancer	7.51e-06	0.000138	CcSEcCtD
Sunitinib—Dry mouth—Paclitaxel—kidney cancer	7.51e-06	0.000138	CcSEcCtD
Sunitinib—Mental disorder—Capecitabine—kidney cancer	7.44e-06	0.000136	CcSEcCtD
Sunitinib—Asthenia—Dactinomycin—kidney cancer	7.44e-06	0.000136	CcSEcCtD
Sunitinib—Blood creatinine increased—Doxorubicin—kidney cancer	7.42e-06	0.000136	CcSEcCtD
Sunitinib—Malnutrition—Capecitabine—kidney cancer	7.4e-06	0.000136	CcSEcCtD
Sunitinib—Erythema—Capecitabine—kidney cancer	7.4e-06	0.000136	CcSEcCtD
Sunitinib—Dehydration—Doxorubicin—kidney cancer	7.36e-06	0.000135	CcSEcCtD
Sunitinib—Oedema—Paclitaxel—kidney cancer	7.36e-06	0.000135	CcSEcCtD
Sunitinib—Abdominal pain—Vincristine—kidney cancer	7.32e-06	0.000134	CcSEcCtD
Sunitinib—Body temperature increased—Vincristine—kidney cancer	7.32e-06	0.000134	CcSEcCtD
Sunitinib—Liver function test abnormal—Doxorubicin—kidney cancer	7.31e-06	0.000134	CcSEcCtD
Sunitinib—Infection—Paclitaxel—kidney cancer	7.31e-06	0.000134	CcSEcCtD
Sunitinib—Flatulence—Capecitabine—kidney cancer	7.29e-06	0.000134	CcSEcCtD
Sunitinib—Dry skin—Doxorubicin—kidney cancer	7.26e-06	0.000133	CcSEcCtD
Sunitinib—Dysgeusia—Capecitabine—kidney cancer	7.24e-06	0.000133	CcSEcCtD
Sunitinib—Shock—Paclitaxel—kidney cancer	7.24e-06	0.000133	CcSEcCtD
Sunitinib—Vomiting—Sorafenib—kidney cancer	7.24e-06	0.000133	CcSEcCtD
Sunitinib—Abdominal pain upper—Doxorubicin—kidney cancer	7.23e-06	0.000133	CcSEcCtD
Sunitinib—Nervous system disorder—Paclitaxel—kidney cancer	7.21e-06	0.000132	CcSEcCtD
Sunitinib—Hypokalaemia—Doxorubicin—kidney cancer	7.21e-06	0.000132	CcSEcCtD
Sunitinib—Thrombocytopenia—Paclitaxel—kidney cancer	7.2e-06	0.000132	CcSEcCtD
Sunitinib—Rash—Sorafenib—kidney cancer	7.18e-06	0.000132	CcSEcCtD
Sunitinib—Dermatitis—Sorafenib—kidney cancer	7.17e-06	0.000131	CcSEcCtD
Sunitinib—Back pain—Capecitabine—kidney cancer	7.16e-06	0.000131	CcSEcCtD
Sunitinib—Skin disorder—Paclitaxel—kidney cancer	7.15e-06	0.000131	CcSEcCtD
Sunitinib—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	7.13e-06	0.000131	CcSEcCtD
Sunitinib—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	7.13e-06	0.000131	CcSEcCtD
Sunitinib—Headache—Sorafenib—kidney cancer	7.13e-06	0.000131	CcSEcCtD
Sunitinib—Muscle spasms—Capecitabine—kidney cancer	7.11e-06	0.00013	CcSEcCtD
Sunitinib—Diarrhoea—Dactinomycin—kidney cancer	7.09e-06	0.00013	CcSEcCtD
Sunitinib—Nasopharyngitis—Doxorubicin—kidney cancer	7.08e-06	0.00013	CcSEcCtD
Sunitinib—Anorexia—Paclitaxel—kidney cancer	7.01e-06	0.000129	CcSEcCtD
Sunitinib—Muscular weakness—Doxorubicin—kidney cancer	6.98e-06	0.000128	CcSEcCtD
Sunitinib—Alanine aminotransferase increased—Doxorubicin—kidney cancer	6.98e-06	0.000128	CcSEcCtD
Sunitinib—Body temperature increased—Gemcitabine—kidney cancer	6.95e-06	0.000127	CcSEcCtD
Sunitinib—Abdominal distension—Doxorubicin—kidney cancer	6.89e-06	0.000126	CcSEcCtD
Sunitinib—Dysphagia—Doxorubicin—kidney cancer	6.84e-06	0.000125	CcSEcCtD
Sunitinib—Anaemia—Capecitabine—kidney cancer	6.84e-06	0.000125	CcSEcCtD
Sunitinib—Hypersensitivity—Vincristine—kidney cancer	6.82e-06	0.000125	CcSEcCtD
Sunitinib—Nausea—Sorafenib—kidney cancer	6.76e-06	0.000124	CcSEcCtD
Sunitinib—Pancreatitis—Doxorubicin—kidney cancer	6.71e-06	0.000123	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Paclitaxel—kidney cancer	6.7e-06	0.000123	CcSEcCtD
Sunitinib—Insomnia—Paclitaxel—kidney cancer	6.65e-06	0.000122	CcSEcCtD
Sunitinib—Asthenia—Vincristine—kidney cancer	6.65e-06	0.000122	CcSEcCtD
Sunitinib—Leukopenia—Capecitabine—kidney cancer	6.62e-06	0.000121	CcSEcCtD
Sunitinib—Paraesthesia—Paclitaxel—kidney cancer	6.61e-06	0.000121	CcSEcCtD
Sunitinib—Vomiting—Dactinomycin—kidney cancer	6.59e-06	0.000121	CcSEcCtD
Sunitinib—Bronchitis—Doxorubicin—kidney cancer	6.58e-06	0.000121	CcSEcCtD
Sunitinib—Dyspnoea—Paclitaxel—kidney cancer	6.56e-06	0.00012	CcSEcCtD
Sunitinib—Rash—Dactinomycin—kidney cancer	6.54e-06	0.00012	CcSEcCtD
Sunitinib—Pancytopenia—Doxorubicin—kidney cancer	6.5e-06	0.000119	CcSEcCtD
Sunitinib—Dyspepsia—Paclitaxel—kidney cancer	6.48e-06	0.000119	CcSEcCtD
Sunitinib—Cough—Capecitabine—kidney cancer	6.45e-06	0.000118	CcSEcCtD
Sunitinib—Neutropenia—Doxorubicin—kidney cancer	6.4e-06	0.000117	CcSEcCtD
Sunitinib—Decreased appetite—Paclitaxel—kidney cancer	6.39e-06	0.000117	CcSEcCtD
Sunitinib—Hypertension—Capecitabine—kidney cancer	6.39e-06	0.000117	CcSEcCtD
Sunitinib—Upper respiratory tract infection—Doxorubicin—kidney cancer	6.36e-06	0.000117	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Paclitaxel—kidney cancer	6.35e-06	0.000116	CcSEcCtD
Sunitinib—Fatigue—Paclitaxel—kidney cancer	6.34e-06	0.000116	CcSEcCtD
Sunitinib—Diarrhoea—Vincristine—kidney cancer	6.34e-06	0.000116	CcSEcCtD
Sunitinib—Asthenia—Gemcitabine—kidney cancer	6.3e-06	0.000116	CcSEcCtD
Sunitinib—Arthralgia—Capecitabine—kidney cancer	6.3e-06	0.000115	CcSEcCtD
Sunitinib—Chest pain—Capecitabine—kidney cancer	6.3e-06	0.000115	CcSEcCtD
Sunitinib—Myalgia—Capecitabine—kidney cancer	6.3e-06	0.000115	CcSEcCtD
Sunitinib—Constipation—Paclitaxel—kidney cancer	6.29e-06	0.000115	CcSEcCtD
Sunitinib—Pain—Paclitaxel—kidney cancer	6.29e-06	0.000115	CcSEcCtD
Sunitinib—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	6.25e-06	0.000115	CcSEcCtD
Sunitinib—Pruritus—Gemcitabine—kidney cancer	6.22e-06	0.000114	CcSEcCtD
Sunitinib—Weight decreased—Doxorubicin—kidney cancer	6.19e-06	0.000113	CcSEcCtD
Sunitinib—Hyperglycaemia—Doxorubicin—kidney cancer	6.17e-06	0.000113	CcSEcCtD
Sunitinib—Dry mouth—Capecitabine—kidney cancer	6.16e-06	0.000113	CcSEcCtD
Sunitinib—Nausea—Dactinomycin—kidney cancer	6.16e-06	0.000113	CcSEcCtD
Sunitinib—Pneumonia—Doxorubicin—kidney cancer	6.14e-06	0.000112	CcSEcCtD
Sunitinib—Dizziness—Vincristine—kidney cancer	6.12e-06	0.000112	CcSEcCtD
Sunitinib—Infestation—Doxorubicin—kidney cancer	6.1e-06	0.000112	CcSEcCtD
Sunitinib—Infestation NOS—Doxorubicin—kidney cancer	6.1e-06	0.000112	CcSEcCtD
Sunitinib—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	6.05e-06	0.000111	CcSEcCtD
Sunitinib—Oedema—Capecitabine—kidney cancer	6.04e-06	0.000111	CcSEcCtD
Sunitinib—Gastrointestinal pain—Paclitaxel—kidney cancer	6.02e-06	0.00011	CcSEcCtD
Sunitinib—Diarrhoea—Gemcitabine—kidney cancer	6.01e-06	0.00011	CcSEcCtD
Sunitinib—Renal failure—Doxorubicin—kidney cancer	6e-06	0.00011	CcSEcCtD
Sunitinib—Infection—Capecitabine—kidney cancer	6e-06	0.00011	CcSEcCtD
Sunitinib—Neuropathy peripheral—Doxorubicin—kidney cancer	5.98e-06	0.00011	CcSEcCtD
Sunitinib—Stomatitis—Doxorubicin—kidney cancer	5.95e-06	0.000109	CcSEcCtD
Sunitinib—Shock—Capecitabine—kidney cancer	5.94e-06	0.000109	CcSEcCtD
Sunitinib—Urinary tract infection—Doxorubicin—kidney cancer	5.93e-06	0.000109	CcSEcCtD
Sunitinib—Nervous system disorder—Capecitabine—kidney cancer	5.92e-06	0.000109	CcSEcCtD
Sunitinib—Thrombocytopenia—Capecitabine—kidney cancer	5.91e-06	0.000108	CcSEcCtD
Sunitinib—Vomiting—Vincristine—kidney cancer	5.89e-06	0.000108	CcSEcCtD
Sunitinib—Skin disorder—Capecitabine—kidney cancer	5.86e-06	0.000107	CcSEcCtD
Sunitinib—Rash—Vincristine—kidney cancer	5.84e-06	0.000107	CcSEcCtD
Sunitinib—Dermatitis—Vincristine—kidney cancer	5.83e-06	0.000107	CcSEcCtD
Sunitinib—Body temperature increased—Paclitaxel—kidney cancer	5.82e-06	0.000107	CcSEcCtD
Sunitinib—Abdominal pain—Paclitaxel—kidney cancer	5.82e-06	0.000107	CcSEcCtD
Sunitinib—Headache—Vincristine—kidney cancer	5.8e-06	0.000106	CcSEcCtD
Sunitinib—Hepatobiliary disease—Doxorubicin—kidney cancer	5.77e-06	0.000106	CcSEcCtD
Sunitinib—Epistaxis—Doxorubicin—kidney cancer	5.76e-06	0.000105	CcSEcCtD
Sunitinib—Anorexia—Capecitabine—kidney cancer	5.75e-06	0.000105	CcSEcCtD
Sunitinib—Vomiting—Gemcitabine—kidney cancer	5.59e-06	0.000102	CcSEcCtD
Sunitinib—Bradycardia—Doxorubicin—kidney cancer	5.58e-06	0.000102	CcSEcCtD
Sunitinib—Rash—Gemcitabine—kidney cancer	5.54e-06	0.000102	CcSEcCtD
Sunitinib—Dermatitis—Gemcitabine—kidney cancer	5.53e-06	0.000101	CcSEcCtD
Sunitinib—Haemoglobin—Doxorubicin—kidney cancer	5.51e-06	0.000101	CcSEcCtD
Sunitinib—Headache—Gemcitabine—kidney cancer	5.5e-06	0.000101	CcSEcCtD
Sunitinib—Nausea—Vincristine—kidney cancer	5.5e-06	0.000101	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Capecitabine—kidney cancer	5.5e-06	0.000101	CcSEcCtD
Sunitinib—Hepatitis—Doxorubicin—kidney cancer	5.48e-06	0.0001	CcSEcCtD
Sunitinib—Haemorrhage—Doxorubicin—kidney cancer	5.48e-06	0.0001	CcSEcCtD
Sunitinib—Insomnia—Capecitabine—kidney cancer	5.46e-06	0.0001	CcSEcCtD
Sunitinib—Hypoaesthesia—Doxorubicin—kidney cancer	5.45e-06	9.99e-05	CcSEcCtD
Sunitinib—Paraesthesia—Capecitabine—kidney cancer	5.42e-06	9.94e-05	CcSEcCtD
Sunitinib—Hypersensitivity—Paclitaxel—kidney cancer	5.42e-06	9.93e-05	CcSEcCtD
Sunitinib—Urinary tract disorder—Doxorubicin—kidney cancer	5.41e-06	9.91e-05	CcSEcCtD
Sunitinib—Oedema peripheral—Doxorubicin—kidney cancer	5.4e-06	9.89e-05	CcSEcCtD
Sunitinib—Connective tissue disorder—Doxorubicin—kidney cancer	5.38e-06	9.86e-05	CcSEcCtD
Sunitinib—Dyspnoea—Capecitabine—kidney cancer	5.38e-06	9.86e-05	CcSEcCtD
Sunitinib—Urethral disorder—Doxorubicin—kidney cancer	5.37e-06	9.84e-05	CcSEcCtD
Sunitinib—Dyspepsia—Capecitabine—kidney cancer	5.31e-06	9.74e-05	CcSEcCtD
Sunitinib—Asthenia—Paclitaxel—kidney cancer	5.28e-06	9.67e-05	CcSEcCtD
Sunitinib—Decreased appetite—Capecitabine—kidney cancer	5.25e-06	9.62e-05	CcSEcCtD
Sunitinib—Nausea—Gemcitabine—kidney cancer	5.22e-06	9.57e-05	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Capecitabine—kidney cancer	5.21e-06	9.55e-05	CcSEcCtD
Sunitinib—Fatigue—Capecitabine—kidney cancer	5.2e-06	9.54e-05	CcSEcCtD
Sunitinib—Pruritus—Paclitaxel—kidney cancer	5.2e-06	9.54e-05	CcSEcCtD
Sunitinib—Erythema multiforme—Doxorubicin—kidney cancer	5.18e-06	9.49e-05	CcSEcCtD
Sunitinib—Pain—Capecitabine—kidney cancer	5.16e-06	9.46e-05	CcSEcCtD
Sunitinib—Constipation—Capecitabine—kidney cancer	5.16e-06	9.46e-05	CcSEcCtD
Sunitinib—Eye disorder—Doxorubicin—kidney cancer	5.12e-06	9.38e-05	CcSEcCtD
Sunitinib—Cardiac disorder—Doxorubicin—kidney cancer	5.08e-06	9.32e-05	CcSEcCtD
Sunitinib—Flushing—Doxorubicin—kidney cancer	5.08e-06	9.32e-05	CcSEcCtD
Sunitinib—Diarrhoea—Paclitaxel—kidney cancer	5.03e-06	9.22e-05	CcSEcCtD
Sunitinib—Angiopathy—Doxorubicin—kidney cancer	4.97e-06	9.11e-05	CcSEcCtD
Sunitinib—Immune system disorder—Doxorubicin—kidney cancer	4.95e-06	9.07e-05	CcSEcCtD
Sunitinib—Gastrointestinal pain—Capecitabine—kidney cancer	4.94e-06	9.05e-05	CcSEcCtD
Sunitinib—Mediastinal disorder—Doxorubicin—kidney cancer	4.94e-06	9.05e-05	CcSEcCtD
Sunitinib—Chills—Doxorubicin—kidney cancer	4.91e-06	9.01e-05	CcSEcCtD
Sunitinib—Arrhythmia—Doxorubicin—kidney cancer	4.89e-06	8.97e-05	CcSEcCtD
Sunitinib—Dizziness—Paclitaxel—kidney cancer	4.86e-06	8.92e-05	CcSEcCtD
Sunitinib—Alopecia—Doxorubicin—kidney cancer	4.84e-06	8.87e-05	CcSEcCtD
Sunitinib—Mental disorder—Doxorubicin—kidney cancer	4.8e-06	8.79e-05	CcSEcCtD
Sunitinib—Abdominal pain—Capecitabine—kidney cancer	4.77e-06	8.75e-05	CcSEcCtD
Sunitinib—Body temperature increased—Capecitabine—kidney cancer	4.77e-06	8.75e-05	CcSEcCtD
Sunitinib—Erythema—Doxorubicin—kidney cancer	4.77e-06	8.74e-05	CcSEcCtD
Sunitinib—Malnutrition—Doxorubicin—kidney cancer	4.77e-06	8.74e-05	CcSEcCtD
Sunitinib—Flatulence—Doxorubicin—kidney cancer	4.7e-06	8.61e-05	CcSEcCtD
Sunitinib—Vomiting—Paclitaxel—kidney cancer	4.68e-06	8.57e-05	CcSEcCtD
Sunitinib—Dysgeusia—Doxorubicin—kidney cancer	4.67e-06	8.56e-05	CcSEcCtD
Sunitinib—Rash—Paclitaxel—kidney cancer	4.64e-06	8.5e-05	CcSEcCtD
Sunitinib—Dermatitis—Paclitaxel—kidney cancer	4.63e-06	8.49e-05	CcSEcCtD
Sunitinib—Back pain—Doxorubicin—kidney cancer	4.61e-06	8.45e-05	CcSEcCtD
Sunitinib—Headache—Paclitaxel—kidney cancer	4.61e-06	8.45e-05	CcSEcCtD
Sunitinib—Muscle spasms—Doxorubicin—kidney cancer	4.58e-06	8.4e-05	CcSEcCtD
Sunitinib—Hypersensitivity—Capecitabine—kidney cancer	4.45e-06	8.15e-05	CcSEcCtD
Sunitinib—Anaemia—Doxorubicin—kidney cancer	4.41e-06	8.08e-05	CcSEcCtD
Sunitinib—Nausea—Paclitaxel—kidney cancer	4.37e-06	8.01e-05	CcSEcCtD
Sunitinib—Asthenia—Capecitabine—kidney cancer	4.33e-06	7.94e-05	CcSEcCtD
Sunitinib—Pruritus—Capecitabine—kidney cancer	4.27e-06	7.83e-05	CcSEcCtD
Sunitinib—Leukopenia—Doxorubicin—kidney cancer	4.27e-06	7.82e-05	CcSEcCtD
Sunitinib—Cough—Doxorubicin—kidney cancer	4.16e-06	7.63e-05	CcSEcCtD
Sunitinib—Convulsion—Doxorubicin—kidney cancer	4.13e-06	7.57e-05	CcSEcCtD
Sunitinib—Diarrhoea—Capecitabine—kidney cancer	4.13e-06	7.57e-05	CcSEcCtD
Sunitinib—Hypertension—Doxorubicin—kidney cancer	4.12e-06	7.54e-05	CcSEcCtD
Sunitinib—Arthralgia—Doxorubicin—kidney cancer	4.06e-06	7.44e-05	CcSEcCtD
Sunitinib—Myalgia—Doxorubicin—kidney cancer	4.06e-06	7.44e-05	CcSEcCtD
Sunitinib—Chest pain—Doxorubicin—kidney cancer	4.06e-06	7.44e-05	CcSEcCtD
Sunitinib—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	4.03e-06	7.39e-05	CcSEcCtD
Sunitinib—Dizziness—Capecitabine—kidney cancer	3.99e-06	7.32e-05	CcSEcCtD
Sunitinib—Dry mouth—Doxorubicin—kidney cancer	3.97e-06	7.28e-05	CcSEcCtD
Sunitinib—Oedema—Doxorubicin—kidney cancer	3.89e-06	7.13e-05	CcSEcCtD
Sunitinib—Infection—Doxorubicin—kidney cancer	3.87e-06	7.09e-05	CcSEcCtD
Sunitinib—Vomiting—Capecitabine—kidney cancer	3.84e-06	7.03e-05	CcSEcCtD
Sunitinib—Shock—Doxorubicin—kidney cancer	3.83e-06	7.02e-05	CcSEcCtD
Sunitinib—Nervous system disorder—Doxorubicin—kidney cancer	3.82e-06	6.99e-05	CcSEcCtD
Sunitinib—Thrombocytopenia—Doxorubicin—kidney cancer	3.81e-06	6.98e-05	CcSEcCtD
Sunitinib—Rash—Capecitabine—kidney cancer	3.81e-06	6.98e-05	CcSEcCtD
Sunitinib—Dermatitis—Capecitabine—kidney cancer	3.8e-06	6.97e-05	CcSEcCtD
Sunitinib—Headache—Capecitabine—kidney cancer	3.78e-06	6.93e-05	CcSEcCtD
Sunitinib—Skin disorder—Doxorubicin—kidney cancer	3.78e-06	6.93e-05	CcSEcCtD
Sunitinib—Anorexia—Doxorubicin—kidney cancer	3.71e-06	6.8e-05	CcSEcCtD
Sunitinib—Nausea—Capecitabine—kidney cancer	3.59e-06	6.57e-05	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Doxorubicin—kidney cancer	3.55e-06	6.5e-05	CcSEcCtD
Sunitinib—Insomnia—Doxorubicin—kidney cancer	3.52e-06	6.45e-05	CcSEcCtD
Sunitinib—Paraesthesia—Doxorubicin—kidney cancer	3.49e-06	6.4e-05	CcSEcCtD
Sunitinib—Dyspnoea—Doxorubicin—kidney cancer	3.47e-06	6.36e-05	CcSEcCtD
Sunitinib—Dyspepsia—Doxorubicin—kidney cancer	3.43e-06	6.28e-05	CcSEcCtD
Sunitinib—Decreased appetite—Doxorubicin—kidney cancer	3.38e-06	6.2e-05	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Doxorubicin—kidney cancer	3.36e-06	6.16e-05	CcSEcCtD
Sunitinib—Fatigue—Doxorubicin—kidney cancer	3.36e-06	6.15e-05	CcSEcCtD
Sunitinib—Pain—Doxorubicin—kidney cancer	3.33e-06	6.1e-05	CcSEcCtD
Sunitinib—Constipation—Doxorubicin—kidney cancer	3.33e-06	6.1e-05	CcSEcCtD
Sunitinib—Gastrointestinal pain—Doxorubicin—kidney cancer	3.18e-06	5.83e-05	CcSEcCtD
Sunitinib—Abdominal pain—Doxorubicin—kidney cancer	3.08e-06	5.64e-05	CcSEcCtD
Sunitinib—Body temperature increased—Doxorubicin—kidney cancer	3.08e-06	5.64e-05	CcSEcCtD
Sunitinib—Hypersensitivity—Doxorubicin—kidney cancer	2.87e-06	5.25e-05	CcSEcCtD
Sunitinib—Asthenia—Doxorubicin—kidney cancer	2.79e-06	5.12e-05	CcSEcCtD
Sunitinib—Pruritus—Doxorubicin—kidney cancer	2.75e-06	5.05e-05	CcSEcCtD
Sunitinib—Diarrhoea—Doxorubicin—kidney cancer	2.66e-06	4.88e-05	CcSEcCtD
Sunitinib—Dizziness—Doxorubicin—kidney cancer	2.57e-06	4.72e-05	CcSEcCtD
Sunitinib—Vomiting—Doxorubicin—kidney cancer	2.47e-06	4.53e-05	CcSEcCtD
Sunitinib—Rash—Doxorubicin—kidney cancer	2.45e-06	4.5e-05	CcSEcCtD
Sunitinib—Dermatitis—Doxorubicin—kidney cancer	2.45e-06	4.49e-05	CcSEcCtD
Sunitinib—Headache—Doxorubicin—kidney cancer	2.44e-06	4.47e-05	CcSEcCtD
Sunitinib—Nausea—Doxorubicin—kidney cancer	2.31e-06	4.24e-05	CcSEcCtD
Sunitinib—JAK2—Immune System—MAPK3—kidney cancer	1.34e-07	2.76e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—RELA—kidney cancer	1.33e-07	2.76e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—PTEN—kidney cancer	1.33e-07	2.76e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—CDKN1B—kidney cancer	1.33e-07	2.76e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—MAPK1—kidney cancer	1.33e-07	2.75e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—CDKN1B—kidney cancer	1.33e-07	2.75e-06	CbGpPWpGaD
Sunitinib—JAK2—GPCR downstream signaling—PIK3CA—kidney cancer	1.33e-07	2.75e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—CTNNB1—kidney cancer	1.33e-07	2.75e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—CTNNB1—kidney cancer	1.33e-07	2.75e-06	CbGpPWpGaD
Sunitinib—FGFR2—Disease—PIK3CA—kidney cancer	1.33e-07	2.74e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—ERBB2—kidney cancer	1.33e-07	2.74e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—PTEN—kidney cancer	1.32e-07	2.72e-06	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—KRAS—kidney cancer	1.31e-07	2.72e-06	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—KRAS—kidney cancer	1.31e-07	2.72e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling by GPCR—KRAS—kidney cancer	1.31e-07	2.72e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—MAPK1—kidney cancer	1.31e-07	2.71e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—KRAS—kidney cancer	1.31e-07	2.71e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—MYC—kidney cancer	1.31e-07	2.71e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—VEGFA—kidney cancer	1.31e-07	2.71e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—MTOR—kidney cancer	1.31e-07	2.71e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—RAF1—kidney cancer	1.31e-07	2.7e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—IL2—kidney cancer	1.3e-07	2.7e-06	CbGpPWpGaD
Sunitinib—KIT—Disease—PIK3CA—kidney cancer	1.3e-07	2.7e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—RELA—kidney cancer	1.3e-07	2.69e-06	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—PIK3CA—kidney cancer	1.3e-07	2.69e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—IL2—kidney cancer	1.3e-07	2.69e-06	CbGpPWpGaD
Sunitinib—FYN—Disease—MAPK3—kidney cancer	1.3e-07	2.68e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—ERBB2—kidney cancer	1.29e-07	2.68e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—PTEN—kidney cancer	1.29e-07	2.68e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—PTEN—kidney cancer	1.29e-07	2.68e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—MAPK3—kidney cancer	1.29e-07	2.67e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CRABP1—kidney cancer	1.29e-07	2.66e-06	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—KRAS—kidney cancer	1.28e-07	2.65e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—MAPK1—kidney cancer	1.28e-07	2.65e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—MTOR—kidney cancer	1.28e-07	2.64e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—CCND1—kidney cancer	1.27e-07	2.63e-06	CbGpPWpGaD
Sunitinib—JAK2—Immune System—MAPK1—kidney cancer	1.27e-07	2.63e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—JUN—kidney cancer	1.27e-07	2.63e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—CCND1—kidney cancer	1.27e-07	2.62e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—JUN—kidney cancer	1.27e-07	2.62e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling by GPCR—PIK3CA—kidney cancer	1.26e-07	2.61e-06	CbGpPWpGaD
Sunitinib—FYN—Immune System—KRAS—kidney cancer	1.26e-07	2.61e-06	CbGpPWpGaD
Sunitinib—FYN—Disease—MYC—kidney cancer	1.26e-07	2.61e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—RAF1—kidney cancer	1.26e-07	2.61e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—CTNNB1—kidney cancer	1.26e-07	2.61e-06	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—TP53—kidney cancer	1.26e-07	2.6e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—CTNNB1—kidney cancer	1.26e-07	2.6e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—KRAS—kidney cancer	1.26e-07	2.6e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—MYC—kidney cancer	1.26e-07	2.6e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—RELA—kidney cancer	1.25e-07	2.6e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—RAF1—kidney cancer	1.25e-07	2.59e-06	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—PIK3CA—kidney cancer	1.25e-07	2.59e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—RELA—kidney cancer	1.25e-07	2.58e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—ERBB2—kidney cancer	1.25e-07	2.58e-06	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—PIK3CA—kidney cancer	1.25e-07	2.58e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—VEGFA—kidney cancer	1.24e-07	2.57e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—ERBB2—kidney cancer	1.24e-07	2.57e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—KRAS—kidney cancer	1.24e-07	2.56e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—MAPK3—kidney cancer	1.24e-07	2.56e-06	CbGpPWpGaD
Sunitinib—FGFR1—Disease—PIK3CA—kidney cancer	1.24e-07	2.56e-06	CbGpPWpGaD
Sunitinib—FYN—Disease—MAPK1—kidney cancer	1.23e-07	2.55e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—PIK3CA—kidney cancer	1.23e-07	2.55e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—PIK3CA—kidney cancer	1.23e-07	2.55e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—MAPK3—kidney cancer	1.23e-07	2.55e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—MTOR—kidney cancer	1.23e-07	2.55e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—MAPK1—kidney cancer	1.23e-07	2.54e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—CDKN1B—kidney cancer	1.23e-07	2.54e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—PTEN—kidney cancer	1.23e-07	2.54e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—GSTP1—kidney cancer	1.23e-07	2.54e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—PTEN—kidney cancer	1.22e-07	2.53e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—MTOR—kidney cancer	1.22e-07	2.53e-06	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—TP53—kidney cancer	1.21e-07	2.51e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—KRAS—kidney cancer	1.21e-07	2.5e-06	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—PIK3CA—kidney cancer	1.21e-07	2.5e-06	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—PIK3CA—kidney cancer	1.21e-07	2.5e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling by GPCR—PIK3CA—kidney cancer	1.21e-07	2.5e-06	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—TP53—kidney cancer	1.2e-07	2.49e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—VEGFA—kidney cancer	1.2e-07	2.49e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—MYC—kidney cancer	1.2e-07	2.49e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—PIK3CA—kidney cancer	1.2e-07	2.49e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—IL2—kidney cancer	1.2e-07	2.49e-06	CbGpPWpGaD
Sunitinib—JAK2—Immune System—KRAS—kidney cancer	1.2e-07	2.48e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—MYC—kidney cancer	1.2e-07	2.48e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—RAF1—kidney cancer	1.2e-07	2.48e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—CDKN1B—kidney cancer	1.2e-07	2.48e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—ITPR2—kidney cancer	1.2e-07	2.47e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—RELA—kidney cancer	1.19e-07	2.47e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—VEGFA—kidney cancer	1.19e-07	2.46e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—ERBB2—kidney cancer	1.19e-07	2.45e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—MAPK1—kidney cancer	1.18e-07	2.44e-06	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—PIK3CA—kidney cancer	1.18e-07	2.43e-06	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—PTGS2—kidney cancer	1.18e-07	2.43e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—MAPK3—kidney cancer	1.17e-07	2.43e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—MAPK1—kidney cancer	1.17e-07	2.43e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—IL2—kidney cancer	1.17e-07	2.43e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—CCND1—kidney cancer	1.17e-07	2.42e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—MTOR—kidney cancer	1.17e-07	2.42e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—JUN—kidney cancer	1.17e-07	2.42e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—VEGFA—kidney cancer	1.17e-07	2.42e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—VEGFA—kidney cancer	1.17e-07	2.42e-06	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—TP53—kidney cancer	1.17e-07	2.42e-06	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—TP53—kidney cancer	1.17e-07	2.42e-06	CbGpPWpGaD
Sunitinib—FYN—Disease—KRAS—kidney cancer	1.17e-07	2.41e-06	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—PTGS2—kidney cancer	1.17e-07	2.41e-06	CbGpPWpGaD
Sunitinib—FYN—Immune System—PIK3CA—kidney cancer	1.16e-07	2.4e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—CTNNB1—kidney cancer	1.16e-07	2.4e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—KRAS—kidney cancer	1.16e-07	2.4e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—CDKN1B—kidney cancer	1.15e-07	2.39e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—PIK3CA—kidney cancer	1.15e-07	2.39e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—CDKN1B—kidney cancer	1.15e-07	2.38e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—CCND1—kidney cancer	1.14e-07	2.36e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—MYC—kidney cancer	1.14e-07	2.36e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—JUN—kidney cancer	1.14e-07	2.36e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—MAPK3—kidney cancer	1.14e-07	2.36e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—PIK3CA—kidney cancer	1.14e-07	2.36e-06	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—TP53—kidney cancer	1.14e-07	2.36e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—CTNNB1—kidney cancer	1.13e-07	2.34e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—PTEN—kidney cancer	1.13e-07	2.34e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—IL2—kidney cancer	1.13e-07	2.34e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—GSTM1—kidney cancer	1.13e-07	2.33e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—MAPK3—kidney cancer	1.13e-07	2.33e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—IL2—kidney cancer	1.12e-07	2.33e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—MAPK1—kidney cancer	1.12e-07	2.31e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—KRAS—kidney cancer	1.11e-07	2.3e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—PIK3CA—kidney cancer	1.11e-07	2.3e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—VEGFA—kidney cancer	1.11e-07	2.29e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—MYC—kidney cancer	1.11e-07	2.29e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—KRAS—kidney cancer	1.11e-07	2.29e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—VEGFA—kidney cancer	1.11e-07	2.29e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—MAPK3—kidney cancer	1.11e-07	2.29e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—MAPK3—kidney cancer	1.11e-07	2.29e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—PTEN—kidney cancer	1.1e-07	2.28e-06	CbGpPWpGaD
Sunitinib—JAK2—Immune System—PIK3CA—kidney cancer	1.1e-07	2.28e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—CCND1—kidney cancer	1.1e-07	2.28e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—JUN—kidney cancer	1.1e-07	2.27e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—CDKN1B—kidney cancer	1.1e-07	2.27e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—CCND1—kidney cancer	1.1e-07	2.27e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—MYC—kidney cancer	1.09e-07	2.26e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—JUN—kidney cancer	1.09e-07	2.26e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—CTNNB1—kidney cancer	1.09e-07	2.26e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—GSTT1—kidney cancer	1.09e-07	2.26e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—ACHE—kidney cancer	1.09e-07	2.26e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—CTNNB1—kidney cancer	1.09e-07	2.24e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—MAPK1—kidney cancer	1.08e-07	2.24e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—MYC—kidney cancer	1.08e-07	2.22e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—MYC—kidney cancer	1.08e-07	2.22e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—IL2—kidney cancer	1.07e-07	2.22e-06	CbGpPWpGaD
Sunitinib—FYN—Disease—PIK3CA—kidney cancer	1.07e-07	2.22e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—MAPK1—kidney cancer	1.07e-07	2.22e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—CYP1A1—kidney cancer	1.07e-07	2.21e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—PIK3CA—kidney cancer	1.07e-07	2.2e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—PTEN—kidney cancer	1.06e-07	2.2e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—PTEN—kidney cancer	1.06e-07	2.19e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—POMC—kidney cancer	1.06e-07	2.19e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—KRAS—kidney cancer	1.06e-07	2.18e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—MAPK1—kidney cancer	1.05e-07	2.18e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—MAPK1—kidney cancer	1.05e-07	2.18e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—MAPK3—kidney cancer	1.05e-07	2.17e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—CCND1—kidney cancer	1.05e-07	2.17e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—MAPK3—kidney cancer	1.05e-07	2.16e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—JUN—kidney cancer	1.05e-07	2.16e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—CTNNB1—kidney cancer	1.04e-07	2.15e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—SCARB1—kidney cancer	1.03e-07	2.14e-06	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—PTEN—kidney cancer	1.03e-07	2.12e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—KRAS—kidney cancer	1.02e-07	2.12e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PTGS1—kidney cancer	1.02e-07	2.11e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—PIK3CA—kidney cancer	1.02e-07	2.11e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—VEGFA—kidney cancer	1.02e-07	2.11e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—MYC—kidney cancer	1.02e-07	2.11e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—PIK3CA—kidney cancer	1.02e-07	2.11e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—MYC—kidney cancer	1.02e-07	2.1e-06	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—PTEN—kidney cancer	1.02e-07	2.1e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—KRAS—kidney cancer	1.01e-07	2.09e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—PTEN—kidney cancer	1.01e-07	2.09e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PSMD7—kidney cancer	1e-07	2.07e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—MAPK1—kidney cancer	9.98e-08	2.06e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—VEGFA—kidney cancer	9.96e-08	2.06e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—MAPK1—kidney cancer	9.96e-08	2.06e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—KRAS—kidney cancer	9.93e-08	2.05e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—KRAS—kidney cancer	9.93e-08	2.05e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—TP53—kidney cancer	9.89e-08	2.04e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—PIK3CA—kidney cancer	9.69e-08	2e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—MAPK3—kidney cancer	9.66e-08	2e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—VEGFA—kidney cancer	9.61e-08	1.99e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—VEGFA—kidney cancer	9.55e-08	1.98e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—BCHE—kidney cancer	9.5e-08	1.97e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—KRAS—kidney cancer	9.43e-08	1.95e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—MAPK3—kidney cancer	9.43e-08	1.95e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—PIK3CA—kidney cancer	9.41e-08	1.95e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—KRAS—kidney cancer	9.4e-08	1.94e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—MYC—kidney cancer	9.4e-08	1.94e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—SLC5A5—kidney cancer	9.39e-08	1.94e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—TP53—kidney cancer	9.38e-08	1.94e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—PIK3CA—kidney cancer	9.29e-08	1.92e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—MAPK1—kidney cancer	9.19e-08	1.9e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—MYC—kidney cancer	9.17e-08	1.9e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—VEGFA—kidney cancer	9.13e-08	1.89e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—PIK3CA—kidney cancer	9.13e-08	1.89e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—PIK3CA—kidney cancer	9.13e-08	1.89e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—TP53—kidney cancer	9.1e-08	1.88e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—MAPK3—kidney cancer	9.09e-08	1.88e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—SLC2A1—kidney cancer	9.07e-08	1.88e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—MAPK3—kidney cancer	9.04e-08	1.87e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—TP53—kidney cancer	8.99e-08	1.86e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—MAPK1—kidney cancer	8.97e-08	1.86e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—MYC—kidney cancer	8.84e-08	1.83e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—TP53—kidney cancer	8.83e-08	1.83e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—TP53—kidney cancer	8.83e-08	1.83e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—MYC—kidney cancer	8.79e-08	1.82e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—KRAS—kidney cancer	8.68e-08	1.8e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—PIK3CA—kidney cancer	8.66e-08	1.79e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—MAPK1—kidney cancer	8.65e-08	1.79e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—PIK3CA—kidney cancer	8.64e-08	1.79e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—MAPK3—kidney cancer	8.64e-08	1.79e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—MAPK1—kidney cancer	8.6e-08	1.78e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—KRAS—kidney cancer	8.47e-08	1.75e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—PTGS2—kidney cancer	8.43e-08	1.74e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—MYC—kidney cancer	8.4e-08	1.74e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—TP53—kidney cancer	8.38e-08	1.73e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—TP53—kidney cancer	8.36e-08	1.73e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—MAPK1—kidney cancer	8.22e-08	1.7e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—KRAS—kidney cancer	8.17e-08	1.69e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—KRAS—kidney cancer	8.12e-08	1.68e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—PIK3CA—kidney cancer	7.98e-08	1.65e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—POMC—kidney cancer	7.97e-08	1.65e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—PIK3CA—kidney cancer	7.78e-08	1.61e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—KRAS—kidney cancer	7.76e-08	1.61e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—TP53—kidney cancer	7.72e-08	1.6e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—GSTP1—kidney cancer	7.56e-08	1.56e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—TP53—kidney cancer	7.53e-08	1.56e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—PIK3CA—kidney cancer	7.5e-08	1.55e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—PIK3CA—kidney cancer	7.46e-08	1.54e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—PTEN—kidney cancer	7.35e-08	1.52e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—TP53—kidney cancer	7.26e-08	1.5e-06	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—PIK3CA—kidney cancer	7.24e-08	1.5e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—TP53—kidney cancer	7.22e-08	1.49e-06	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—PIK3CA—kidney cancer	7.17e-08	1.48e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—ABCB1—kidney cancer	7.16e-08	1.48e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—PIK3CA—kidney cancer	7.13e-08	1.48e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—GSTM1—kidney cancer	6.95e-08	1.44e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—TP53—kidney cancer	6.9e-08	1.43e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CYP1A1—kidney cancer	6.59e-08	1.36e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—PTGS2—kidney cancer	6.36e-08	1.32e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—PTEN—kidney cancer	5.55e-08	1.15e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—PIK3CA—kidney cancer	5.18e-08	1.07e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—POMC—kidney cancer	4.91e-08	1.02e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PTGS2—kidney cancer	3.92e-08	8.1e-07	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—PIK3CA—kidney cancer	3.91e-08	8.09e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PTEN—kidney cancer	3.42e-08	7.07e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PIK3CA—kidney cancer	2.41e-08	4.99e-07	CbGpPWpGaD
